Approach toward molecular targeted therapy for cancer using microbial products

Approach toward molecular targeted therapy for cancer using microbial products
- Masaya Imoto
Special Feature Editorial27 Sep 2021 The Journal of Antibiotics
Splicing modulators: on the way from nature to clinic
- Tilman Schneider-Poetsch
- Jagat Krishna Chhipi-Shrestha
- Minoru Yoshida
Special Feature Review ArticleOpen Access3 Aug 2021 The Journal of Antibiotics
Chemical targeting of G-quadruplexes in telomeres and beyond for molecular cancer therapeutics
- Hiroyuki Seimiya
- Kazuo Nagasawa
- Kazuo Shin-ya
Special Feature Review Article20 Jul 2021 The Journal of Antibiotics
Screening study of cancer-related cellular signals from microbial natural products
- Masami Ishibashi
Special Feature Review Article30 Jun 2021 The Journal of Antibiotics
Proteomics-based target identification of natural products affecting cancer metabolism
- Makoto Muroi
- Hiroyuki Osada
Special Feature Review Article20 Jul 2021 The Journal of Antibiotics
Domestication of chemicals attacking metazoan embryogenesis: identification of safe natural products modifying developmental signaling pathways in human
- Naoyuki Nishiya
- Honami Yonezawa
Special Feature Review Article11 Aug 2021 The Journal of Antibiotics
Phenotypic screening system using three-dimensional (3D) culture models for natural product screening
- Hikaru Suenaga
- Noritaka Kagaya
- Kazuo Shin-ya
Special Feature Review Article29 Jul 2021 The Journal of Antibiotics
Naturally occurring small molecule compounds that target histone deacetylases and their potential applications in cancer therapy
- Yuki Maemoto
- Yuki Shimizu
- Akihiro Ito
Special Feature Review Article23 Aug 2021 The Journal of Antibiotics
Natural products targeting cancer cell dependency
- Changxiang Shi
- Eun Ju Yang
- Joong Sup Shim
Special Feature Review Article23 Jun 2021 The Journal of Antibiotics
Targeting hypoxia-inducible factor 1 (HIF-1) signaling with natural products toward cancer chemotherapy
- Hiroaki Ikeda
- Hideaki Kakeya
Special Feature Review Article30 Jul 2021 The Journal of Antibiotics
The therapeutic potential of mitochondrial toxins
- Manabu Kawada
- Masahide Amemiya
- Tomokazu Ohishi
Special Feature Review Article23 Jun 2021 The Journal of Antibiotics
Androgen receptor antagonists produced by Streptomyces overcome resistance to enzalutamide
- Masaya Imoto
- Takahiro Fujimaki
- Etsu Tashiro
Special Feature Review Article19 Jul 2021 The Journal of Antibiotics
Androprostamine A: a unique antiprostate cancer agent
- Yohko Yamazaki
- Hikaru Abe
- Manabu Kawada
Special Feature Article28 Jul 2021 The Journal of Antibiotics
Daptomycin suppresses tumor migration and angiogenesis via binding to ribosomal protein S19 in humans
- Sung Min Cho
- Hwa Jung Lee
- Ho Jeong Kwon
Special Feature Article12 Jul 2021 The Journal of Antibiotics
Structure-activity relationships of natural quinone vegfrecine analogs with potent activity against VEGFR-1 and -2 tyrosine kinases
- Hayamitsu Adachi
- Chisato Nosaka
- Yoshio Nishimura
Special Feature Article20 Jul 2021 The Journal of Antibiotics
The potent protein phosphatase 2A inhibitors aminocytostatins: new derivatives of cytostatin
- Shigehiro Tohyama
- Manabu Kawada
- Masayuki Igarashi
Special Feature Article21 Jul 2021 The Journal of Antibiotics
Pulveraven A from the fruiting bodies of Pulveroboletus ravenelii induces apoptosis in breast cancer cell via extrinsic apoptotic signaling pathway
- Dahae Lee
- Jae Sik Yu
- Ki Hyun Kim
Special Feature Brief Communication25 Jun 2021 The Journal of Antibiotics
Quinofuracins F – I, new quinofuracin derivatives produced by Staphylotrichum boninense PF1444
- Daisuke Tatsuda
- Masahide Amemiya
- Manabu Kawada
Special Feature Brief Communication29 Jul 2021 The Journal of Antibiotics
Rationally repurposed nitroxoline inhibits preclinical models of Epstein–Barr virus-associated lymphoproliferation
- Maite Ibáñez de Garayo
- Wendi Liu
- JJ L. Miranda
Special Feature Brief CommunicationOpen Access23 Jun 2021 The Journal of Antibiotics
Author Correction: Androprostamine A: a unique antiprostate cancer agent
- Yohko Yamazaki
- Hikaru Abe
- Manabu Kawada
Correction18 Aug 2021 The Journal of Antibiotics

Approach toward molecular targeted therapy for cancer using microbial products

Contents

Approach toward molecular targeted therapy for cancer using microbial products

Splicing modulators: on the way from nature to clinic

Chemical targeting of G-quadruplexes in telomeres and beyond for molecular cancer therapeutics

Screening study of cancer-related cellular signals from microbial natural products

Proteomics-based target identification of natural products affecting cancer metabolism

Domestication of chemicals attacking metazoan embryogenesis: identification of safe natural products modifying developmental signaling pathways in human

Phenotypic screening system using three-dimensional (3D) culture models for natural product screening

Naturally occurring small molecule compounds that target histone deacetylases and their potential applications in cancer therapy

Natural products targeting cancer cell dependency

Targeting hypoxia-inducible factor 1 (HIF-1) signaling with natural products toward cancer chemotherapy

The therapeutic potential of mitochondrial toxins

Androgen receptor antagonists produced by Streptomyces overcome resistance to enzalutamide

Androprostamine A: a unique antiprostate cancer agent

Daptomycin suppresses tumor migration and angiogenesis via binding to ribosomal protein S19 in humans

Structure-activity relationships of natural quinone vegfrecine analogs with potent activity against VEGFR-1 and -2 tyrosine kinases

The potent protein phosphatase 2A inhibitors aminocytostatins: new derivatives of cytostatin

Pulveraven A from the fruiting bodies of Pulveroboletus ravenelii induces apoptosis in breast cancer cell via extrinsic apoptotic signaling pathway

Quinofuracins F – I, new quinofuracin derivatives produced by Staphylotrichum boninense PF1444

Rationally repurposed nitroxoline inhibits preclinical models of Epstein–Barr virus-associated lymphoproliferation

Author Correction: Androprostamine A: a unique antiprostate cancer agent

Search

Quick links